USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Feb 2, 2022 | Dec 2021 | $-0.21 | - | $-0.37 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Feb 2, 2022 | Dec 2021 | $0.00 | - | $0.00 |
Brainstorm Cell Therapeutics's next earnings date is Wednesday, Feb 2, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $-0.21 | $-0.24 | $-0.17 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $-0.82 | $-1.02 | $-0.70 |
| Dec 2022 | 3 | $-0.94 | $-1.25 | $-0.79 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.21 | $-0.21 | $-0.22 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.82 | $-0.82 | $-0.80 |
| Dec 2022 | 0 / 0 | $-0.94 | $-0.94 | $-0.53 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 3 | $12.63M | $0.00 | $37.90M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Oct 13, 2021 | Sep 2021 | $-0.20 | - | - |
| Aug 5, 2021 | Jun 2021 | $-0.20 | $-0.17 | 15.00% |
| Apr 26, 2021 | Mar 2021 | $-0.26 | $-0.19 | 26.92% |
| Feb 4, 2021 | Dec 2020 | $-0.20 | $-0.37 | -89.74% |
| Oct 15, 2020 | Sep 2020 | $-0.26 | $-0.14 | 45.10% |
| Aug 5, 2020 | Jun 2020 | $-0.26 | $-0.25 | 1.96% |
| May 7, 2020 | Mar 2020 | $-0.22 | $-0.32 | -45.45% |
| Feb 18, 2020 | Dec 2019 | $-0.20 | $-0.34 | -70.00% |
| Nov 14, 2019 | Sep 2019 | $-0.22 | $-0.25 | -13.64% |
| Aug 13, 2019 | Jun 2019 | $-0.19 | $-0.23 | -21.05% |
| May 10, 2019 | Mar 2019 | $-0.11 | $-0.24 | -118.18% |
| Mar 29, 2019 | Dec 2018 | $-0.14 | $-0.27 | -92.86% |
| Oct 29, 2018 | Sep 2018 | $-0.16 | $-0.15 | 6.25% |
| Jul 23, 2018 | Jun 2018 | $-0.13 | $-0.16 | -26.28% |
| May 14, 2018 | Mar 2018 | $-0.14 | $-0.12 | 14.29% |
| Mar 8, 2018 | Dec 2017 | $-0.09 | $0.03 | 133.33% |
| Oct 17, 2017 | Sep 2017 | $-0.16 | $-0.13 | 18.75% |
| Aug 14, 2017 | Jun 2017 | $-0.13 | $-0.06 | 52.00% |
| May 15, 2017 | Mar 2017 | $-0.17 | $-0.10 | 41.18% |
| Mar 29, 2017 | Dec 2016 | $-0.09 | $-0.04 | 52.94% |
| Nov 14, 2016 | Sep 2016 | $-0.11 | $-0.09 | 14.29% |
| Aug 11, 2016 | Jun 2016 | $-0.14 | $-0.05 | 64.29% |
| May 10, 2016 | Mar 2016 | $-0.08 | $-0.10 | -25.00% |
| Mar 9, 2016 | Dec 2015 | $-0.15 | $-0.08 | 46.67% |
| Nov 16, 2015 | Sep 2015 | $-0.15 | $-0.14 | 6.67% |
| Aug 13, 2015 | Jun 2015 | $-0.14 | $-0.12 | 14.29% |
| May 14, 2015 | Mar 2015 | $-0.13 | $-0.12 | 7.69% |
| Mar 26, 2015 | Dec 2014 | $-0.15 | $-0.18 | -20.00% |
| Nov 13, 2014 | Sep 2014 | $-0.20 | $-0.16 | 20.00% |
| Sep 3, 2014 | Jun 2014 | - | $-0.16 | - |
| May 28, 2014 | Mar 2014 | - | $-0.18 | - |
| Feb 26, 2014 | Dec 2013 | - | $-0.15 | - |
| Sep 30, 2013 | Sep 2013 | - | $-0.10 | - |
| Jun 30, 2013 | Jun 2013 | - | $-0.15 | - |
| Mar 31, 2013 | Mar 2013 | - | $-0.11 | - |
| Dec 31, 2012 | Dec 2012 | - | $-0.06 | - |
| Sep 30, 2012 | Sep 2012 | - | $-0.12 | - |
| Jun 30, 2012 | Jun 2012 | - | $-0.10 | - |
| Mar 31, 2012 | Mar 2012 | - | $-0.10 | - |
| Dec 31, 2011 | Dec 2011 | - | $-0.18 | - |
| Sep 30, 2011 | Sep 2011 | - | $-0.08 | - |
| Jun 30, 2011 | Jun 2011 | - | $-0.14 | - |
| Mar 31, 2011 | Mar 2011 | - | $-0.10 | - |
| Dec 31, 2010 | Dec 2010 | - | $-0.08 | - |
| Sep 30, 2010 | Sep 2010 | - | $-0.12 | - |
| Jun 30, 2010 | Jun 2010 | - | $-0.10 | - |
| Mar 31, 2010 | Mar 2010 | - | $-0.11 | - |
| Dec 31, 2009 | Dec 2009 | - | $-0.03 | - |
| Sep 30, 2009 | Sep 2009 | - | $-0.15 | - |
| Jun 30, 2009 | Jun 2009 | - | $-0.14 | - |
| Mar 31, 2009 | Mar 2009 | - | $-0.14 | - |
| Dec 31, 2008 | Dec 2008 | - | $-0.15 | - |
| Sep 30, 2008 | Sep 2008 | - | $-0.21 | - |
| Jun 30, 2008 | Jun 2008 | - | $-0.27 | - |
| Mar 31, 2008 | Mar 2008 | - | $-0.45 | - |
| Dec 31, 2007 | Dec 2007 | - | $-0.75 | - |
| Sep 30, 2007 | Sep 2007 | - | $-0.60 | - |
| Jun 30, 2007 | Jun 2007 | - | $-1.06 | - |
| Mar 31, 2007 | Mar 2007 | - | $-1.06 | - |
| Mar 31, 2005 | Mar 2005 | - | $-0.45 | - |
| Dec 31, 2004 | Dec 2004 | - | $-12.31 | - |
| Sep 30, 2004 | Sep 2004 | - | $-1.52 | - |
| Jun 30, 2004 | Jun 2004 | - | $0.03 | - |
| Mar 31, 2004 | Mar 2004 | - | $-0.03 | - |
| Dec 31, 2003 | Dec 2003 | - | $-0.01 | - |
| Sep 30, 2003 | Sep 2003 | - | $-0.01 | - |
| Jun 30, 2003 | Jun 2003 | - | $-0.01 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 4, 2021 | Dec 2020 | $-0.89 | $-1.08 | - |
| Feb 18, 2020 | Dec 2019 | $-0.89 | $-1.06 | - |
| Mar 29, 2019 | Dec 2018 | $-0.57 | $-0.70 | - |
| Mar 8, 2018 | Dec 2017 | $-0.58 | $-0.26 | - |
| Mar 29, 2017 | Dec 2016 | - | $-0.28 | - |
| Mar 9, 2016 | Dec 2015 | - | $-0.46 | - |
| Mar 26, 2015 | Dec 2014 | - | $-0.68 | - |
| Feb 26, 2014 | Dec 2013 | - | $-0.51 | - |
| Dec 31, 2012 | Dec 2012 | - | $-0.38 | - |
| Dec 31, 2011 | Dec 2011 | - | $-0.49 | - |
| Dec 31, 2010 | Dec 2010 | - | $-0.41 | - |
| Dec 31, 2009 | Dec 2009 | - | $-0.46 | - |
| Dec 31, 2008 | Dec 2008 | - | $-1.08 | - |
| Dec 31, 2007 | Dec 2007 | - | $-3.93 | - |
| Dec 31, 2004 | Dec 2004 | - | $-13.84 | - |
| Dec 31, 2003 | Dec 2003 | - | $-0.03 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Oct 13, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 5, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| Apr 26, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Feb 4, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Oct 15, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 5, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 7, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Feb 18, 2020 | Dec 2019 | $750.00K | $0.00 | - |
| Nov 14, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 13, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 10, 2019 | Mar 2019 | $750.00K | $0.00 | - |
| Mar 29, 2019 | Dec 2018 | $750.00K | $0.00 | - |
| Oct 29, 2018 | Sep 2018 | $750.00K | $0.00 | - |
| Jul 23, 2018 | Jun 2018 | $1.50M | $0.00 | - |
| May 14, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Mar 8, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Oct 17, 2017 | Sep 2017 | - | $0.00 | - |
| Aug 14, 2017 | Jun 2017 | - | $0.00 | - |
| May 15, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 29, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 14, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 11, 2016 | Jun 2016 | - | $0.00 | - |
| May 10, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 9, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 16, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 13, 2015 | Jun 2015 | - | $0.00 | - |
| May 14, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 13, 2014 | Sep 2014 | - | $0.00 | - |
| Sep 3, 2014 | Jun 2014 | - | $0.00 | - |
| May 28, 2014 | Mar 2014 | - | $0.00 | - |
| Feb 26, 2014 | Dec 2013 | - | $0.00 | - |
| Sep 30, 2013 | Sep 2013 | - | $0.00 | - |
| Jun 30, 2013 | Jun 2013 | - | $0.00 | - |
| Mar 31, 2013 | Mar 2013 | - | $0.00 | - |
| Dec 31, 2012 | Dec 2012 | - | $0.00 | - |
| Sep 30, 2012 | Sep 2012 | - | $0.00 | - |
| Jun 30, 2012 | Jun 2012 | - | $0.00 | - |
| Mar 31, 2012 | Mar 2012 | - | $0.00 | - |
| Dec 31, 2011 | Dec 2011 | - | $0.00 | - |
| Sep 30, 2011 | Sep 2011 | - | $0.00 | - |
| Jun 30, 2011 | Jun 2011 | - | $0.00 | - |
| Mar 31, 2011 | Mar 2011 | - | $0.00 | - |
| Dec 31, 2010 | Dec 2010 | - | $0.00 | - |
| Sep 30, 2010 | Sep 2010 | - | $0.00 | - |
| Jun 30, 2010 | Jun 2010 | - | $0.00 | - |
| Mar 31, 2010 | Mar 2010 | - | $0.00 | - |
| Dec 31, 2009 | Dec 2009 | - | - | - |
| Sep 30, 2009 | Sep 2009 | - | - | - |
| Jun 30, 2009 | Jun 2009 | - | - | - |
| Mar 31, 2009 | Mar 2009 | - | - | - |
| Dec 31, 2008 | Dec 2008 | - | - | - |
| Sep 30, 2008 | Sep 2008 | - | - | - |
| Jun 30, 2008 | Jun 2008 | - | - | - |
| Mar 31, 2008 | Mar 2008 | - | - | - |
| Dec 31, 2007 | Dec 2007 | - | - | - |
| Sep 30, 2007 | Sep 2007 | - | - | - |
| Jun 30, 2007 | Jun 2007 | - | - | - |
| Mar 31, 2007 | Mar 2007 | - | - | - |
| Mar 31, 2005 | Mar 2005 | - | - | - |
| Dec 31, 2004 | Dec 2004 | - | - | - |
| Sep 30, 2004 | Sep 2004 | - | - | - |
| Jun 30, 2004 | Jun 2004 | - | - | - |
| Mar 31, 2004 | Mar 2004 | - | - | - |
| Dec 31, 2003 | Dec 2003 | - | - | - |
| Sep 30, 2003 | Sep 2003 | - | - | - |
| Jun 30, 2003 | Jun 2003 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 4, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Feb 18, 2020 | Dec 2019 | $750.00K | $0.00 | - |
| Mar 29, 2019 | Dec 2018 | $750.00K | $0.00 | - |
| Mar 8, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Mar 29, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 9, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
| Feb 26, 2014 | Dec 2013 | - | $0.00 | - |
| Dec 31, 2012 | Dec 2012 | - | $0.00 | - |
| Dec 31, 2011 | Dec 2011 | - | $0.00 | - |
| Dec 31, 2010 | Dec 2010 | - | - | - |
| Dec 31, 2009 | Dec 2009 | - | - | - |
| Dec 31, 2008 | Dec 2008 | - | - | - |
| Dec 31, 2007 | Dec 2007 | - | - | - |
| Dec 31, 2004 | Dec 2004 | - | - | - |
| Dec 31, 2003 | Dec 2003 | - | - | - |
BCLI's next earnings date is Wednesday, Feb 2, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Brainstorm Cell Therapeutics's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.24, and a high estimation of $-0.17.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.21, the last 2 month trend is $-0.21, and the 3 month trend is $-0.22.
Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Brainstorm Cell Therapeutics's previous earnings date was Oct 13, 2021 for its fiscal quarter ended Sep 30, 2021.
Brainstorm Cell Therapeutics's previous annual earnings date was Feb 4, 2021 for its fiscal year ended Dec 31, 2020.
BCLI's earnings per share (EPS) was $-1.08, missing the consensus analysts forecast of $-0.89 by 21.35% , and lower than the previous year's EPS (Dec 2019) by 1.89%.
Revenues were $0.00.
The company reported a net income of $-31.81M.
Brainstorm Cell Therapeutics reported a free cash flow of $-35.57M for its fiscal year, compared to $-11.72M a year ago.
The company ended the fiscal year with $7.22M in total debt, an increase of 205.03% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.